Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

3.7K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.7K
The Neuromuscular Junction01:19

The Neuromuscular Junction

11.9K
The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...
11.9K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

2.1K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.1K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

774
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
774
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

554
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
554
Chemical Synapses01:26

Chemical Synapses

9.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in Exposures of US Children Ages 12 and Under to Cannabis from 2000 to 2024.

Journal of addiction medicine·2026
Same author

Role of the Emergency Medicine Pharmacist in the Management of Boarding Patients: An Opinion of the Emergency Medicine Practice and Research Network of the American College of Clinical Pharmacy Endorsed by the SAEM Academy of Emergency Medicine Pharmacists and the Society of Emergency Medicine Pharmacists.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

A 25-year analysis of Armillaria (honey mushroom) poisoning in Wisconsin.

The American journal of emergency medicine·2026
Same author

Association between state-level kratom regulations and poison center-reported severe medical outcomes and healthcare use: A United States national analysis.

Addiction (Abingdon, England)·2026
Same author

Optimization of benzodiazepine use for status epilepticus in the emergency department.

The American journal of emergency medicine·2026
Same author

Lidocaine for diphenhydramine-induced ventricular tachycardia: A case report.

The American journal of emergency medicine·2026
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Related Experiment Video

Updated: Sep 18, 2025

Levator Auris Longus Preparation for Examination of Mammalian Neuromuscular Transmission Under Voltage Clamp Conditions
10:45

Levator Auris Longus Preparation for Examination of Mammalian Neuromuscular Transmission Under Voltage Clamp Conditions

Published on: May 5, 2018

9.5K

Neuromuscular junction toxins.

Matthew C Randall1, Ryan Feldman2

  • 1SUNY Upstate Medical University, 750 E Adams St, Syracuse, NY 13210, USA.

Disease-A-Month : DM
|June 20, 2025
PubMed
Summary
This summary is machine-generated.

Neurotoxins frequently target the neuromuscular junction (NMJ), causing muscle weakness. Understanding their diverse mechanisms is key for diagnosis, treatment, and developing new therapies.

Keywords:
AcetylcholineNeuromuscular junctionPoisonSynapseToxin

More Related Videos

Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury
04:44

Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury

Published on: November 1, 2024

555
Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions
08:41

Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions

Published on: August 14, 2021

8.9K

Related Experiment Videos

Last Updated: Sep 18, 2025

Levator Auris Longus Preparation for Examination of Mammalian Neuromuscular Transmission Under Voltage Clamp Conditions
10:45

Levator Auris Longus Preparation for Examination of Mammalian Neuromuscular Transmission Under Voltage Clamp Conditions

Published on: May 5, 2018

9.5K
Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury
04:44

Author Spotlight: Regenerative Roles of Muscle Proteins at Neuromuscular Junction Post-Nerve Injury

Published on: November 1, 2024

555
Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions
08:41

Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions

Published on: August 14, 2021

8.9K

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • The neuromuscular junction (NMJ) lacks protective barriers, making it vulnerable to neurotoxins.
  • Diverse natural and synthetic toxins target the NMJ, originating from animals, plants, bacteria, and chemical synthesis.
  • These toxins exploit various mechanisms to disrupt neuromuscular transmission.

Purpose of the Study:

  • To review the mechanisms of neurotoxins targeting the neuromuscular junction.
  • To highlight the clinical presentation and diagnostic considerations for NMJ toxin exposure.
  • To emphasize the importance of understanding these toxins for therapeutic development.

Main Methods:

  • Literature review of neurotoxins affecting the neuromuscular junction.
  • Analysis of toxin mechanisms, including receptor interactions and neurotransmitter modulation.
  • Clinical case review and diagnostic strategies for NMJ toxin-induced syndromes.

Main Results:

  • NMJ toxins act via diverse mechanisms, including acetylcholine receptor antagonism/agonism and inhibition of neurotransmitter release/degradation.
  • Clinical manifestations commonly include muscle weakness, potentially progressing to respiratory failure.
  • Accurate diagnosis relies on recognizing varied presentations and clinical context.

Conclusions:

  • Understanding NMJ toxin mechanisms is crucial for early recognition and management.
  • Knowledge of these toxins informs the judicious use of current treatments.
  • This understanding is vital for the development of novel therapeutic interventions for NMJ-related conditions.